Novelion Therapeutics (NVLN) Posts Q2 Loss of $0.08 on Revenue of $40.9M

Go back to Novelion Therapeutics (NVLN) Posts Q2 Loss of $0.08 on Revenue of $40.9M
(NASDAQ: NVLN) Delayed: 0.68 --0 (-0%)
Previous Close $0.68    52 Week High
Open $0.01    52 Week Low
Day High $0.68    P/E N/A 
Day Low $0.68    EPS
Volume 408,294